HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louis J Aronne Selected Research

lorcaserin

1/2019Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options.
1/2018Pharmacotherapy for obesity in individuals with type 2 diabetes.
1/2017Use of lorcaserin for glycemic control in patients with type 2 diabetes mellitus.
1/2017Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study.
4/2015Efficacy comparison of medications approved for chronic weight management.
3/2015Treatment of obesity in 2015.
1/2015Lorcaserin Hcl for the treatment of obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Louis J Aronne Research Topics

Disease

47Obesity
06/2022 - 12/2003
45Weight Loss (Weight Reduction)
06/2022 - 12/2003
14Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2007
12Body Weight (Weight, Body)
01/2022 - 02/2006
9Overweight
01/2021 - 02/2006
4Weight Gain
12/2021 - 11/2009
4Hypertension (High Blood Pressure)
08/2017 - 02/2007
4Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 01/2007
3Prediabetic State (Prediabetes)
01/2021 - 01/2019
3Insulin Resistance
12/2007 - 01/2007
2Dyslipidemias (Dyslipidemia)
07/2013 - 12/2007
2Nausea
09/2008 - 02/2006
2Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2007 - 02/2007
1COVID-19
01/2021
1Feeding and Eating Disorders (Eating Disorder)
08/2019
1Abdominal Pain (Pain, Abdominal)
01/2017
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2017
1Drug-Related Side Effects and Adverse Reactions
01/2016
1Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
07/2015
1Familial Partial Lipodystrophy (Dunnigan Syndrome)
07/2015
1Metabolic Diseases (Metabolic Disease)
07/2015
1Non-alcoholic Fatty Liver Disease
07/2015
1Lipodystrophy
07/2015
1Alcoholism (Alcohol Abuse)
07/2014
1Coronary Disease (Coronary Heart Disease)
07/2013
1Hypertrophy
07/2013
1Sleep Deprivation
11/2009
1Atherosclerosis
12/2007
1Vascular Diseases (Vascular Disease)
12/2007
1Inflammation (Inflammations)
03/2007

Drug/Important Bio-Agent (IBA)

8Phentermine (Adipex-P)FDA LinkGeneric
08/2018 - 09/2010
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2007
7lorcaserinIBA
01/2019 - 01/2015
7Orlistat (Xenical)FDA Link
01/2019 - 12/2003
7Topiramate (Topamax)FDA LinkGeneric
08/2018 - 02/2012
7RimonabantIBA
05/2008 - 02/2006
6Metformin (Glucophage)FDA LinkGeneric
01/2021 - 02/2007
6LipidsIBA
01/2018 - 02/2006
5Pharmaceutical PreparationsIBA
01/2019 - 02/2006
5Bupropion (Wellbutrin)FDA LinkGeneric
01/2018 - 03/2015
5Naltrexone (ReVia)FDA LinkGeneric
01/2018 - 03/2015
5sibutramine (Meridia)FDA Link
09/2010 - 12/2003
4Hormones (Hormone)IBA
10/2011 - 03/2007
4EndocannabinoidsIBA
05/2008 - 12/2007
3Insulin (Novolin)FDA Link
12/2021 - 01/2017
3CarbohydratesIBA
12/2021 - 01/2017
3LiraglutideFDA Link
01/2019 - 03/2015
3LeptinIBA
07/2015 - 12/2007
3AdiponectinIBA
02/2008 - 12/2007
3Triglycerides (Triacylglycerol)IBA
02/2008 - 03/2007
3CytokinesIBA
12/2007 - 02/2007
3HDL CholesterolIBA
12/2007 - 02/2007
2Biological ProductsIBA
12/2021 - 01/2007
2HydrogelsIBA
07/2019 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2017
2Biomarkers (Surrogate Marker)IBA
10/2011 - 02/2008
2Anti-Obesity Agents (Antiobesity Drugs)IBA
09/2011 - 12/2007
2CannabinoidsIBA
07/2011 - 02/2008
2pramlintide (Symlin)FDA Link
09/2010 - 09/2008
2C-Reactive ProteinIBA
02/2008 - 12/2007
1Peptides (Polypeptides)IBA
01/2022
1Glucagon-Like Peptide-1 ReceptorIBA
01/2022
1tirzepatideIBA
01/2022
1SolutionsIBA
01/2022
1immunoglobulin BIBA
08/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Dihydrotachysterol (AT 10)IBA
01/2020
1ElectrolytesIBA
08/2019
1antineoplaston A10 (A 10)IBA
10/2018
1Antihypertensive Agents (Antihypertensives)IBA
08/2017
1Testosterone (Sustanon)FDA Link
01/2017
1metreleptinIBA
07/2015
1recombinant methionyl human leptinIBA
07/2015
1Adrenergic Agents (Adrenergic Drugs)IBA
04/2015
1Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
01/2015
1NicotineFDA Link
07/2014
1Zonisamide (Zonegran)FDA LinkGeneric
08/2013
1Lipoproteins (Lipoprotein)IBA
07/2013
1GhrelinIBA
10/2011
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
07/2011
1Endocrine DisruptorsIBA
11/2009
1LDL CholesterolIBA
02/2008
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2007
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2007

Therapy/Procedure

21Drug Therapy (Chemotherapy)
06/2022 - 02/2007
17Therapeutics
01/2021 - 12/2003
9Bariatric Surgery
06/2021 - 07/2013
4Glycemic Control
01/2020 - 07/2011
3Gastroplasty (Vertical-Banded Gastroplasty)
01/2021 - 04/2017
3Gastric Bypass (Roux-en-Y Gastric Bypass)
12/2018 - 05/2013
3Gastrectomy
12/2018 - 01/2018
3Obesity Management
04/2017 - 07/2014
2Contraindications
01/2016 - 04/2015
2Caloric Restriction
03/2015 - 06/2007
1Resistance Training
10/2018
1Perioperative Period
01/2017
1Gastrostomy
01/2017
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
07/2015
1Diet Therapy (Therapy, Diet)
03/2015